Abstract: A method for estimating a state of health (SOH) of a battery includes obtaining a state of charge (SOC)-open circuit voltage (OCV) lookup table according to a SOH of a battery module or battery pack, and storing the SOC-OCV lookup table in a memory, calculating, based on a diagnosis time and a current rate, a first SOC change amount when the diagnosis time and the current rate are input, calculating a first slope for each SOC section corresponding to the first SOC change amount according to the SOH in the SOC-OCV lookup table according to the SOH, and determining, based on the first slope, first sections having high diagnostic accuracy.

Abstract: The present disclosure relates to a composition capable of diagnosing cancer, specifically pancreatic cancer or the like, a diagnostic kit comprising the same, and a method of providing information for diagnosis using the composition. Also, the present disclosure relates to a pharmaceutical composition capable of preventing or treating pancreatic cancer.

Abstract: The present invention relates to a composition capable of preventing or treating cancer, particularly pancreatic cancer. The composition can effectively inhibit the growth or proliferation of cancer cells, and furthermore, effectively prevent the resistance of cancer cells to anticancer agents, or the metastasis or recurrence of cancer, by using an inhibitor of the activity of at least one of interleukin-10 receptor subunit beta (IL-10RB, IL-10R2) and interleukin-22 (IL-22); or an inhibitor of expression of a gene encoding at least one of the interleukin-10 receptor subunit beta and the interleukin-22.

Abstract: The present invention relates to biomarkers capable of diagnosing various brain and nervous system diseases, and a method of providing information for diagnosing brain and nervous system diseases using the same. According to the present invention, it is possible to diagnose, at an early stage, the onset of a brain and nervous system disease or the likelihood of developing the disease or diagnose the progress or prognosis of the disease or the therapeutic effect against the disease, by measuring the expression level of the biomarker protein of the present invention or a gene encoding the same in the aqueous humor of the eye.

Abstract: The present invention relates to a composition for diagnosis of pancreatic diseases, more specifically, to a composition which can diagnose pancreatic cancer, a kit for diagnosis comprising the same, and a method of providing information for diagnosis using the composition. The present invention can accurately predict or identify the risk of pancreatic cancer, and moreover, can diagnose pancreatic cancer by effectively distinguishing pancreatic cancer from different types of cancer. In addition, in the present invention, it is possible to diagnose pancreatic cancer simply and rapidly through a non-invasive method by using monocytes obtained from blood, serum or plasma obtained from an individual.

Abstract: Provided are an electrolyte for a sodium secondary battery, and a sodium secondary battery using the same, and the sodium secondary battery using the electrolyte for a sodium secondary battery according to the present invention may have an excellent cycle characteristic, charge-discharge capacity, and stability, thereby making it possible to be operated without deterioration at a low temperature for a long time.

Abstract: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.

Abstract: The present disclosure relates to a novel tetrahydropyridine derivative compound, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, methods for preparing the compounds, methods for inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), methods for treating Gram-negative bacterial infections, the use of the compounds for the preparation of therapeutic medicaments for treating Gram-negative bacterial infections, and pharmaceutical compositions for prevention or treatment of Gram-negative bacterial infections, which contain the compounds. The compounds represented by formula I, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure can exhibit excellent effects on the treatment bacterial infections.

Abstract: A Schottky barrier diode includes an epitaxial layer of a first conductivity type and located on a substrate, a first well of a second conductivity type and positioned on the first conductive epitaxial layer, a plurality of first conductive layers disposed on a surface of the substrate including the first well, the first conductive layers being spaced apart from each other, an impurity region of the second conductivity type, located on the first well and disposed spaced apart outwardly from the first conductive layers and a second conductive layer located on the impurity region. The Schottky barriers disclosed improve electrical field handling and obviate the need for a p-type barrier.

Abstract: The present invention relates to a pharmaceutical composition for the treatment of eye pain, containing a PGE2 synthesis inhibitor. The use of the pharmaceutical composition for the prevention or treatment of eye pain according to the present invention, which contains the PGE2 synthesis inhibitor as an active ingredient, makes it possible to alleviate the symptoms of eye pain by selectively inhibiting the PGE2 expression level, and also has the advantages of treating and preventing xerophthalmia and of overcoming and preventing eye discomfort caused by various inflammation-inducing circumstances including following surgery. Also, by using a kit for detecting the amount of PGE2, PGD2 and COX2, the present invention makes it possible to easily diagnose eye-pain symptoms in clinical practice, and can be widely used in checking the state not only of patients having xerophthalmia but also patients following eye surgery.

Abstract: Provided are an electrolyte for a sodium secondary battery, and a sodium secondary battery using the same, and the sodium secondary battery using the electrolyte for a sodium secondary battery according to the present invention may have an excellent cycle characteristic, charge-discharge capacity, and stability, thereby making it possible to be operated without deterioration at a low temperature for a long time.

Abstract: A method and apparatus for correcting location information of mobile communication terminals is disclosed. The apparatus for correcting location information of mobile communication terminals, includes: a handler to collect location measurement information of the mobile communication terminals, and environment information containing locations of base stations and arrangements of roads or buildings from a network; a database to store the location measurement information and the environment information; an analysis unit to analyze the location measurement information and the environment information to generate correction maps; a correction map database to store the correction maps; and a service unit to refer to the correction maps and to provide a corrected location estimate service, a corrected location measurement service, or a correction-value broadcast service to mobile communication terminals which request location services.

Abstract: Disclosed is a lithium secondary battery, which is low in capacity loss after overdischarge, having excellent capacity restorability after overdischarge and shows an effect of preventing a battery from swelling at a high temperature.

Abstract: The present invention relates to a pharmaceutical composition for the treatment of eye pain, containing a PGE2 synthesis inhibitor. The use of the pharmaceutical composition for the prevention or treatment of eye pain according to the present invention, which contains the PGE2 synthesis inhibitor as an active ingredient, makes it possible to alleviate the symptoms of eye pain by selectively inhibiting the PGE2 expression level, and also has the advantages of treating and preventing xerophthalmia and of overcoming and preventing eye discomfort caused by various inflammation-inducing circumstances including following surgery. Also, by using a kit for detecting the amount of PGE2, PGD2 and COX2, the present invention makes it possible to easily diagnose eye-pain symptoms in clinical practice, and can be widely used in checking the state not only of patients having xerophthalmia but also patients following eye surgery.

Abstract: Disclosed is a lithium secondary battery, which is low in capacity loss after overdischarge, having excellent capacity restorability after overdischarge and shows an effect of preventing a battery from swelling at a high temperature.

Abstract: Disclosed is a lithium secondary battery, which is low in capacity loss after overdischarge, having excellent capacity restorability after overdischarge and shows an effect of preventing a battery from swelling at a high temperature.

Abstract: Disclosed is a lithium secondary battery, which is low in capacity loss after overdischarge, having excellent capacity restorability after overdischarge and shows an effect of preventing a battery from swelling at a high temperature.

Abstract: The present invention provides a multi-component composite film comprising a) polymer support layer, and b) porous gellable polymer layer which is formed on one side or both sides of the support layer of a), wherein the support film of a) and the gellable polymer layer of b) are unified without the interface, a method for preparing the same, and a polymer electrolyte system applied the same.

Abstract: Disclosed is an exhaust gas treating system having an exhaust gas treating apparatus for carbon dioxide capture process which additionally removes harmful substances remaining in the gas discharged from the existing flue-gas desulfurization process by using separation membrane so as to efficiently carry out the carbon dioxide capture process. The exhaust gas treating system using polymer membrane, comprises a carbon dioxide capture equipment for capturing carbon dioxide from the exhaust gas of a boiler, a flue-gas denitrification equipment placed between the boiler and the carbon dioxide capture equipment, a dust-collecting equipment and a flue-gas desulfurization equipment.

Abstract: Disclosed are an exhaust gas treating apparatus and a treating method for a carbon dioxide capture process, in which harmful substances remaining in the exhaust gas discharged from the conventional flue-gas desulfurization process are additionally removed for efficient performance of the carbon dioxide capture process. According to the exhaust gas treating apparatus for a carbon dioxide capture process, it has the effects of minimizing the installation space of desulfurization equipment and reducing the process cost. In addition, by keeping the contaminants contained in the gas introduced in the carbon dioxide capture equipment below a proper level, absorption performance can be improved as degradation of the absorbent used in the carbon dioxide capture process is prevented. After all, it has an advantage of preventing the pollution by the exhaust gas discharged into the atmosphere.